IRTC רווח נקי למניה ב-12 החודשים האחרונים irhythmtech.com
iRhythm Technologies (IRTC) is implementing the Zio AI system for the automated recognition of arrhythmias based on ECG data, streamlining the workflow for physicians. The TTM net income per share confirms the model's efficiency, where -1.17 reflects the latest metric value. High physician confidence in the accuracy of wearable sensors strengthens the brand image, although a narrow product range and potential reductions in insurance reimbursements create certain risks.
%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%91%D7%90%D7%A8%D7%91%D7%A2%D7%AA%20%D7%94%D7%A8%D7%91%D7%A2%D7%95%D7%A0%D7%99%D7%9D%20%D7%94%D7%90%D7%97%D7%A8%D7%95%D7%A0%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_IRTC_-_iRhythm-Technologies_-_Earnings-per-share-for-the-last-four-quarters "iRhythm Corp - רווח נקי למניה (EPS TTM) IRTC (תקופה 04.07.2022 - 12.11.2026) | 👁️GURU.Markets👁️")
פילוחים אנליטיים של חברת iRhythm Technologies, Inc. (IRTC)
The scalability of iRhythm Technologies (IRTC) AI algorithms in cardiology diagnostics is directly reflected in the TTM net income per share distribution. This indicator is calculated by dividing the total annual net income by the total number of shares, allowing investors to assess real capital generation efficiency and promptly identify margin compression risks amid expensive debt financing.
